See every side of every news story
Get Started
SubscribeLogin
Israel-Hamas Conflict
Marine Le Pen
Eid
Social Media
Natural Disasters
Artificial Intelligence
Donald Trump
Tariffs
Baseball
Stock Markets
Taxes
European Union
Amazon
Published • loading... • Updated

Chiesi pours €430 into new Italy site; Bharat’s first CGT site in India - Endpoints News

Summary by MondialNews
In a meaningful boost to its European and Asian operations, Chiesi Farmaceutici has announced a substantial investment of €430 million to establish a new facility in Italy, aimed at enhancing its capacity to develop and manufacture pharmaceutical products.This enterprising initiative underscores the company’s commitment to expanding its production capabilities and meeting the growing demand for innovative therapies. Concurrently, Bharat Biotech …
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

4 Articles

All
Left
Center
Right
MondialNewsMondialNews

Chiesi pours €430 into new Italy site; Bharat’s first CGT site in India - Endpoints News

In a meaningful boost to its European and Asian operations, Chiesi Farmaceutici has announced a substantial investment of €430 million to establish a new facility in Italy, aimed at enhancing its capacity to develop and manufacture pharmaceutical products.This enterprising initiative underscores the company’s commitment to expanding its production capabilities and meeting the growing demand for innovative therapies. Concurrently, Bharat Biotech …

Read Full Article
PharmaphorumPharmaphorum

Chiesi backs growth plans with a €430m new plant in Italy

Fast-growing pharma group Chiesi has revealed plans to spend €430m on a new therapeutics manufacturing facility at its site in Milan

Read Full Article
Endpoints NewsEndpoints News

Chiesi pours €430 into new Italy site; Bharat’s first CGT site in India

Welcome to Endpoints News’ manufacturing briefs, where we bring you essential news on new builds, collaborations, recalls and more. Chiesi is investing €430 million ($358 million) over the next five years ...

Read Full Article
European Pharmaceutical ManufacturerEuropean Pharmaceutical Manufacturer

Chiesi acquires new manufacturing site in Nerviano

Chiesi Group, a biopharmaceutical company headquartered in Parma, Italy, has announced an investment in Nerviano (Milan, Italy), with the construction of a new facility for the production of its therapeutic solutions.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

European Pharmaceutical Manufacturer broke the news in on Thursday, March 27, 2025.
Sources are mostly out of (0)

Similar News Topics

Product Recalls

Product Recalls

Italy

Italy

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.

News
For You
SearchBlindspotLocal